Clinical Trial Update: A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial compared cardiovascular effects of ticagrelor versus clopidogrel in patients with peripheral artery disease; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: AstraZeneca | Conditions: Peripheral Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-10-30